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AbstrAct
Introduction The Human Transplantation (Wales) 
Act 2013 (the Act) introduced a ‘soft opt-out’ system 
of organ donation on 1 December 2015. Citizens are 
encouraged to make their organ donation decision known 
during their lifetime. In order to work, the Act and media 
campaign need to create a context, whereby organ 
donation becomes the norm, and create a mechanism 
for people to behave as intended (formally register their 
decision; consider appointing a representative; convey 
their donation decision to their families and friends or do 
nothing—deemed consent). In addition, family members/
appointed representatives need to be able to put their own 
views aside to support the decision of their loved one. 
The aim of this study is to evaluate initial implementation, 
outcomes and impact on families and appointed 
representatives who were approached about organ 
donation during the first 18 months.
Methods and analysis Prospective mixed-method 
coproductive study undertaken with National Health 
Service Blood and Transplant (NHSBT), and multiple 
patient/public representatives. The study is designed 
to collect information on all cases who meet specified 
criteria (≥18 years, deceased person voluntarily resident 
in Wales and died in Wales or England) whose family 
were approached between 1 December 2015 and 31 
June 2017). Data for analysis include: NHSBT routinely 
collected anonymised audit data on all cases; Specialist 
Nurse in Organ Donation (SNOD) completed anonymised 
form for all cases documenting their perception of the 
families’ understanding of the Act, media campaign and 
outcome of the donation approach; questionnaires and 
depth interviews with any family member or appointed 
representative (minimum 50 cases). Additional focus 
groups and interviews with SNODs. Anonymised donation 
outcomes and registration activity reports for Wales 
provide additional context.
Ethics and dissemination Approved by NHSBT Research, 
Innovation and Technology Advisory Group on 23 October 
2015; Wales Research Ethics Committee 5 (IRAS190066; 
Rec Reference 15/WA/0414) on 25 November 2015 and 
NHSBT R&D Committee (NHSBT ID: AP-15–02) on 24 
November 2015.
registration The protocol is registered on the Health and 
Care Research Wales Clinical Research Portfolio. Study ID 
number 34396, www. ukctg. nihr. ac. uk
IntroductIon
The Human Transplantation (Wales) Act 
2013 introduced a ‘soft opt-out’ system of 
organ donation.1 In an ‘opt-out’ system 
presumed consent means that unless the 
deceased person has expressed a wish in life 
not to be an organ donor then consent will 
be assumed (or deemed in Wales). There are 
two types of ‘opt-out’ system: a ‘hard opt-out’ 
where the family is not consulted or a ‘soft 
opt-out’ where the family is consulted.2 
The purpose of the Act is to make it easier 
for people to donate their organs to benefit 
patients. The Act is central to the Wales 
Action Plan,3 which sets out a programme 
of continuous improvement on all aspects 
of organ donation and transplantation to 
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Protocol
strengths and limitations of this study
 ► The study is a large-scale prospective mixed-
method evaluation of the immediate impact of the 
Act using multiple data sources.
 ► Previous studies have struggled to recruit family 
members involved in an organ donation approach.
 ► The success of this study is dependent on the 
multiple recruitment strategies and the engagement 
of NHS Blood and Transplant staff who will primarily 
recruit participants.
 ► NHS Blood and Transplant is an equal partner in this 
coproductive study.
 ► Many patient and public representatives and 
organisations are supporting the study.
 ► CRUSE Bereavement Care Cymru is supplying 
bereavement support information for bereaved 
families who participate in the study.
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deliver the NHS Blood and Transplant (NHSBT) strategy 
‘Taking Organ Transplantation to 2020’.4 NHSBT is a 
Special Health Authority in England and Wales (account-
able to the Department of Health) that is responsible 
for promoting tissue and organ donation to the public 
and managing organ donation and transplantation. The 
overall target of the strategy is to increase the UK consent 
rates to 80% by 2020. Under the former ‘opt-in’ system, 
in 2012/2013, 2013/2014 and 2014/2015 only 50.3%, 
53.6% and 48.5% of families consented to deceased dona-
tion in Wales, respectively.5 In contrast, the consent rate 
in Spain, which operates an ‘opt-out’ system in which all 
citizens are automatically registered for organ donation 
unless they choose to state otherwise, ranged between 
80% and 85%.4 6
Wales has a devolved parliamentary legislature within 
the UK and a population of just over 3 million people. 
Responsibility for healthcare legislation is devolved to 
the Welsh Government. The Human Transplantation 
(Wales) Act 2013 constitutes one of the biggest changes 
to the partnership and social contract between the Welsh 
Government and the people of Wales. The Act is however 
controversial and not everyone consulted agreed with 
the ‘soft opt-out’ system and its principle of deemed 
consent.7 8
Potential donor families are considered to be most 
affected by the Act as, unlike the old ‘opt-in’ system, their 
role in the ‘soft opt-out’ system remains essential but 
changed by deemed consent.9 Under the previous ‘opt-in’ 
system, which came under the Human Tissue Act 2004,10 
if the individual’s consent had not been indicated by the 
deceased person or a nominated representative, consent 
was sought from the person who was in a ‘qualifying rela-
tionship' with the deceased person immediately before 
their death (usually a family member). If the decision 
regarding donation was unknown then families were less 
likely to give consent.9 11 If those close to the deceased 
person objected to organ donation, for whatever purpose, 
when the deceased person (or their nominated repre-
sentative) had explicitly consented, they did not have the 
legal right to revoke the consent, however the existence of 
appropriate, valid consent permitted donation to proceed, 
but did not mandate that it must. The final decision about 
whether to proceed rested with the medical team when 
family members did not support donation.
How tHE IntErvEntIon Is IntEndEd to work?
In a research context, the Act and implementation 
strategy is conceptualised as a complex behaviour change 
intervention.12 The Act changes the principles of consent 
to deceased organ donation from one of 'opt-in’ to a ‘soft 
opt-out’ for adults who are 18 years or over; voluntarily 
resident for 12 months or more in Wales; who have not 
made an express decision regarding organ donation 
and is competent to understand the notion of deemed 
consent. The individual must also die in Wales for the Act 
to apply.
NHSBT employ teams of Specialist Nurses in Organ 
Donation (SNODs), who work across regions to support 
the organ donation process.13 The choices individuals 
now have in either expressing their organ donation deci-
sion or choosing to do nothing and having their consent 
deemed (criteria apply) have impacted on the approach 
to the family by the SNODs. Once the SNODs have ascer-
tained that the individual has not recorded their organ 
donation decision on the Organ Donor Register (ODR) 
and has not appointed a representative to make the deci-
sion on their behalf, the conversation with the family 
is presumptive in favour of organ donation, informing 
them if applicable their relatives’ consent will be deemed 
to have been given. During the conversation, the family is 
able to inform the SNODs that their relative did not want 
to be an organ donor. In this circumstance, the family is 
required to produce clear evidence that the person did 
not want to be an organ donor. The Act is permissive in 
the sense that it allows for consent to be deemed in certain 
circumstances, however, it does not mandate that organ 
donation goes ahead in such cases. If an individual has 
registered a decision or informed someone that they did 
not want to donate organs prior to their death, their deci-
sion will be respected unless the family is able to produce 
clear evidence that the individual had changed his/her 
mind.
IntEndEd bEHAvIour cHAngE
The success of the Act depends on behaviour change 
(public and professional) to work as intended. The 
theory is that the neutral media campaigns supporting 
implementation will facilitate five behaviours:
1. People will register to ‘opt-in’ on the organ donor
register and appoint a patient representative;
2. they register to ‘opt-out’;
3. people will discuss their donation decision with fami-
lies and friends;
4. people can do nothing and it will be assumed that
they do not object to organ donation (deemed con-
sent);
5. in making the donation decision, families will put
aside their own views on donation and respect the
decision of the deceased person.
Overall, this complex intervention addresses four 
components of behaviour change as outlined in the 
Nuffield Council of Bioethics ladder of intervention 
(figure 1).14 The Act and implementation strategy were 
designed to change the default position so that organ 
donation became the norm. The Government-led media 
campaign was however presented in a neutral way to 
provide people with information to make an informed 
choice. Nudge theory was also used to underpin behav-
iour change—such as exposing the population of Wales 
to a series of ‘nudge alerts’ via email, Royal Mail and the 
media to do specific things such as making their organ 
donation decision known and ‘opting in’ or ‘out’ on 
the organ donation register.14 The media did however 
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Figure 1 Nuffield council of bioethics ladder of intervention.
generally present organ donation as having positive bene-
fits (eg, giving the gift of life).
In addition to the public media campaign, there was 
an accompanying implementation strategy for NHS and 
NHSBT staff, which required amending clinical protocols 
and procedures and retraining large numbers of staff and 
all SNODs covering Wales. The multiple elements of this 
complex intervention are shown visually in figures 2, 3 
and 4.
ModIfIcAtIons to tHE ApproAcH convErsAtIon undEr 
tHE Act
The SNOD facilitates an approach conversation with the 
family at the point indicated in figure 5.
After 1 December 2015, for deceased people who have 
not registered to ‘opt-out’ on the ODR, the approach 
to families will be a presumptive conversation in favour 
of organ donation. The sequence of obtaining consent 
for deceased organ donation when the patient has not 
recorded their decision on the ODR is shown in figure 6. 
Irrespective of whether the deceased person is regis-
tered on the ODR or not, the assumption is that family 
members will put aside their own beliefs if different to 
the deceased person and support the express decision 
to donate or by choosing not to register a decision by 
any means support their relative’s deemed consent.
prudEnt HEAltHcArE prIncIplEs
The Act is conceived as a Prudent healthcare policy. Any 
Prudent health service or intervention is based on the 
following four principles15 16:
 ► Achieve health and well-being with the public, patients 
and professionals as equal partners through copro-
duction. Patient and public contribution is essential 
to create a patient-centred system for both potential 
donors and transplant recipients.15 16 The soft opt-out 
system has been developed in close consultation with 
the people of Wales.17–20
 ► Care for those with the greatest health need first, 
making the most effective use of all skills and resources. 
The principles underpinning organ transplantation 
decisions are founded on caring for those with the 
greatest health need first, irrespective of ability to pay. 
There is good evidence that all transplants are cost-ef-
fective. For example, the cost benefit of kidney trans-
plantation compared with dialysis over a period of 10 
years (the median transplant survival time) is £241 000 
or £24 100 per year for each year that the patient has 
a functioning transplanted kidney.21 Although the Act 
covers all organs and tissues from which patients may 
benefit from cost-effective transplants, the case for 
economic renewal and regeneration is best made in 
Wales by increasing the number of kidney transplants. 
Kidney transplants are highly cost-effective particu-
larly in relation to NHS spend, and is the treatment of 
choice for many patients with end-stage renal failure. 
Recipients can often engage more productively in the 
economy once they no longer need dialysis.
 ► Do only what is needed, no more, no less; and do no 
harm. The ‘soft opt-out’ is designed to make it easier 
for the people of Wales to become organ donors. 
Transplantation is designed to offer patients more 
options for their treatment with increased benefits 
that outweigh the risks.
 ► Reduce inappropriate variation using evidence-
based practices consistently and transparently. Atti-
tudes to organ donation vary across Wales and across 
social gradients and cultures.20 The purpose of the 
neutral media campaign is to reduce this variation 
by providing the public with high-quality accessible 
information.
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Figure 2 Intervention implementation: multifaceted media-based strategy to inform the public of the Act and changes to 
consenting to organ donation.
 5Noyes J, et al. BMJ Open 2017;7:e017287. doi:10.1136/bmjopen-2017-017287
Open Access
Figure 3 Intervention and required behaviours following 
introduction of the Act.
Figure 4 Intervention implementation: additional training 
for Specialist Nurses in Organ Donation (SNOD) when 
approaching families following the implementation of deemed 
consent.
rAtIonAlE for tHE study
There is evidence from a UK context describing the 
multiple converging factors that appear to influence 
donation decisions under the ‘opt-in’ system, such as 
knowledge of the deceased’s wishes and the view of fami-
lies that the deceased person had suffered enough.15–20 
We want to specifically explore the perspectives of organ 
donor registration and deemed consent with families and 
close friends who were involved in an organ donation 
decision.
This study is designed to address a critical gap in under-
standing by exploring if the Act has changed the views 
and decisions of families. The research is needed to 
understand donor family responses, which could have an 
immediate impact on the design of future interventions to 
change behaviours. Understanding how and why people 
in reality respond to the ‘soft opt-out’ will be vital to 
contextualising the impact of this Prudent health policy 
in achieving its aims. We want to explore what happened 
and ascertain the perspectives and decisions made by indi-
viduals who were involved in an organ donation decision, 
and to explore whether the donation decision reflected 
the patient or family view. There is also a potential benefit 
to participants as the study provides a confidential inde-
pendent opportunity to talk about their views and experi-
ences, which in turn can be used to benefit future donor 
families and patients.
Findings will fill a critical gap in knowledge to supple-
ment the Welsh Government impact evaluation and shed 
light on the mechanisms that prevent or enhance organ 
and tissue donation under the new ‘soft opt-out’ system. 
Undertaking research to better understand these mecha-
nisms and how they work will be vital for policy makers, 
healthcare professionals working in NHSBT and the NHS 
in general. It will inform continuous service improvement 
to realise the intended outcomes of this very complex 
intervention (the Act, media-based behaviour change 
interventions, retraining of NHS and NHSBT staff and 
the interventions of NHS and NHSBT teams when 
requesting consent).
AIM
The aim of the study is to explore the impact of the Act 
on consent for deceased organ and tissue donation in the 
new ‘soft opt-out’ system. A secondary aim is to further 
build research capacity in NHSBT and Patient and Public 
Involvement (PPI) representatives in Wales.
rEsEArcH quEstIons
1. What impact and changes has the Act and media
campaign had on the views and decisions of families 
of potential organ donors in Wales?
2. What were the views of the deceased person and how
did families take account of the deceased person’s 
view in the decision-making process?
3. What are the views of families of the deceased person
on the shift in relationship with the Government 
and healthcare services; organ donor registration; 
deemed consent; express patient decision and role 
of appointed representatives and the changed role of 
families in decision making in a ‘soft opt-out’ system?
objEctIvEs
1. To ascertain a broad overview of anonymised family
views, actions and outcomes from organ donation 
conversations in Wales for an 18-month period 
following implementation of the Act.
2. To explore in greater depth the perspectives and ex-
periences of families who were involved in a donation 
conversation.
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Figure 5 Wales potential organ donor population and identification of the ‘donation request’ stage in the process.
Figure 6 Sequence of obtaining consent when the patient is NOT on the Organ Donor Register (ODR).
3. To explore the perspectives of SNODs and their man-
agers covering Wales to contextualise potential donor
family views, experiences and decisions.
4. To contextualise findings with Welsh Government sur-
vey data and contemporaneous and previous NHSBT
activity reports on organ donor registration and organ
donation in Wales.
5. To further develop research capacity and capability
in NHSBT and patient and public representatives in
Wales.
MEtHods And AnAlysIs
We consulted widely and extensively with multiple key 
stakeholders to design an ethically defensible and sensi-
tive study that respects the vulnerability and confidenti-
ality of bereaved potential donor families and the dignity 
of the deceased family member. The four-phase design 
(figure 7) combines use of routinely collected donor 
audit activity and national attitudinal surveys as context to 
a primary study using shared anonymised and routinely 
collected NHSBT information on decision-making 
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Figure 7 The four-phase study design. NHSBT, National 
Health Service Blood and Transplant; OD, organ donation; 
SNOD, Specialist Nurse in Organ Donation.
processes and outcomes of the donation consent process, 
and interviews with Welsh potential deceased donor fami-
lies/appointed representatives/close friends and organ 
donation professionals covering Wales (see online supple-
mentary file 1) for a summary of all data sources contrib-
uting to the analysis). Recruitment and data capture 
targets for each phase are shown in figure 7.
Phase I: primary study to gain a high level understanding 
of the impact on donor family responses (accepting the 
patient’s decision, or consenting to, or not consenting to 
donation) for 18 months from 1 December 2015.
SNODs will complete an anonymised electronic one 
page form (see online supplementary file 2): form B for 
every approach conversation that will be filled out as soon 
as possible after they have disengaged from speaking with 
the potential donor family. No participant or patient 
identifiable information will be recorded. SNODs will 
complete the form (electronic or paper) using infor-
mation gathered from their routine conversations with 
potential donor families.
Phase II: primary study with potential deceased 
donor families/appointed representatives and close 
friends to ascertain a deeper understanding of their 
thoughts, experiences and responses to the Act and their 
decision making.
Family members/appointed representatives and close 
friends, directly or indirectly involved in the donation 
process, will be invited to self-complete an anonymised 
questionnaire (see online supplementary file 3): form C 
that requires no contact with the research team. There is 
no restriction on the number of questionnaires per family 
and the questionnaire will take around 20 min to complete. 
Accompanying the questionnaire will be an invitation to 
participate in an interview to discuss their views and expe-
riences in greater depth and a contact form to send back to 
the independent research team to arrange a mutually conve-
nient interview (see online supplementary file 4  family 
interview schedule). For those wanting also to participate 
in an interview, several options will be offered that best suit 
the individual, such as face to face, telephone or via social 
media. Mindful that participants have been bereaved, they 
can select the time that is right for them to be interviewed 
up until the end of the period of data collection.
recruitment of family/close friend/appointed representative
We will use a range of methods that are sensitive and 
individually tailored to recruit participants involved in 
a minimum of 50 potential organ donation cases, with 
maximum variation to cover all donation pathways and 
outcomes. SNODs will use their discretion and knowl-
edge of the family to select the most appropriate options 
and times to share information about the study with 
families/appointed representatives. Recruitment options 
include via direct contact with families by SNODs (with 
the option to using consent to contact form), and sharing 
study information in person; and by sending out a study 
invitation with information attached to routine follow-up 
communication by NHSBT; by direct mailing of study 
invitation and information by NHSBT; via adverts in the 
media, and through snowball sampling.
If an individual receives more than one letter of invi-
tation, we will include a sentence to explain that, if they 
have already made their decision whether to participate 
in the study or not, they can ignore the letter or pass the 
invitation onto another family member or close friend 
of the deceased person, because NHSBT only have one 
contact name for each family. For participants who would 
prefer to be interviewed in their first language (Welsh 
or other language), we have employed a Welsh medium 
research officer and have built-in interpreter costs.
Inclusion criteria for ‘family’ participant recruitment
 ► Any person over 16 years with mental capacity who was 
involved, either directly or indirectly, in a deceased 
organ donation conversation or decision in Wales 
after 1 December 2015.
 ► Any person over 16 years with mental capacity who was 
involved, either directly or indirectly, in a deceased 
organ donation conversation or decision of a Welsh 
resident who died in a hospital in England after 1 
December 2015 and was managed by the NHSBT 
organ donation teams covering North or South Wales.
 ► Any close friends of the deceased person who may 
want to share their perspectives on the donation 
process and outcome.
 ► Any NHSBT SNODs and managers covering Wales.
Exclusion criteria for ‘family’ participant recruitment
 ► Under 16 years.
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 ► Lacking mental capacity.
 ► Potential donor was a Welsh resident over 18 years 
who died in an English hospital not covered by partic-
ipating SNODs.
Phase III: primary study with qualitative 1:1 or small or 
focus group interviews with NHSBT organ donation teams 
covering Wales (SNODs and managers in our coproduc-
tive project) to contextualise potential donor family deci-
sion making, reactions and responses to the Act.
SNODs and their managers will be invited by letter with 
accompanying study information to participate in 1:1 or 
small or focus group interviews at the end of the study to 
contextualise the findings. Interviews will be at the end of 
the study and last approximately 60 min.
Phase IV: comparative analysis and overarching 
synthesis of stages 1–3.
Study data will be analysed and findings contextualised 
with descriptive numerical data and additional narra-
tive data shared by NHSBT and Welsh Government (see 




With consent, interviews will be digitally recorded and 
transcribed verbatim in the original language. The frame-
work approach for analysis of applied policy research will 
be used for all narrative textual data from questionnaires, 
focus groups and interviews.22 We will use NVivo software 
V.1123 to facilitate the framework analysis.22 First, the 
initial five available verbatim free text in questionnaires 
and interview transcripts will be read and reread and key 
themes and categories will be identified. The definitions 
and boundaries of each of the emerging themes for each 
type of evidence from questionnaires, focus groups and 
interviews will then be discussed to see how these can 
be developed to form an a priori framework tailored for 
either questionnaires or transcripts in Welsh and English. 
Searching for additional themes will continue until 
all text from questionnaires and interview transcripts 
have been analysed and no new themes are discerned. 
Following analysis of Welsh language text, themes and 
relevant quotes will then be translated into English and 
back translated.
The final themes and their dimensions for text from 
questionnaires and interviews will then be further refined 
and used as the basis of charts (or matrices), which allows 
for themes to be compared and displayed for question-
naires and interviews, and for variations and deviant cases 
to be highlighted within each dataset. These charts will 
be overlaid with key information to preserve the original 
context. Second, these charts will undergo several revi-
sions and further refinements, in an iterative process 
moving between the charts and the themes identified 
from questionnaires and interviews, until it is possible to 
synthesise the key findings across the datasets in a set of 
overall themes or categories. This stage will involve what 
is sometimes called the translation of themes from one 
data source to another. In the process of comparing the 
themes, we will look for explicit differences in relation to a 
range of factors that impact on decision making including 
gender, relationship of the person to the deceased, age, 
ethnicity and whether consent for donation was given 
or not and whether registration as an organ donor was 
viewed positively or negatively.
categorical questionnaire data
Completed form B and C will contain structured cate-
gorical options (such as yes, no, uncertain), which will 
be collated in SPSS V.22 and analysed using descriptive 
statistics.24 Results will be displayed as numbers and 
percentages.
comparative analysis and overarching synthesis
We will use Oliver’s synthesis framework for juxtaposing 
evidence across phases I–III with Welsh Government 
omnibus surveys and contemporaneous and previous 
NHSBT activity reports listed in online supplemen-
tary appendix 1.25 We will organise data by donation 
decision (opt in opt out on organ donation register; 
expressed decision, deemed consent) mapped against 
whether families supported the donation decision and 
why. We will layer the descriptive numerical and narra-
tive findings onto the framework to synthesise find-
ings across the different types of evidence, working 
within each of the spheres of influence (the patient 
decision, family, NHSBT, NHS and clinical care, the 
law, the media campaign, previous comparative data, 
etc). Juxtaposing different numerical, narrative and 
temporal evidence in this way on the same phenom-
enon of interest will enable us to look for patterns, 
explanations, mechanisms and disconfirming cases.
As there is not a specific reporting guideline for 
mixed-method studies, we will draw on new guidance 
for reporting mixed-method syntheses26 and the Consol-
idated Criteria for Reporting Qualitative Research 
guidelines.27
Ethics and dissemination
This protocol was approved on 23 October 2015 by 
NHSBT Research, Innovation and Technology Advisory 
Group. The study was approved by the Wales Research 
Ethics Committee 5 NHS research ethics committee 
(IRAS number 190066; Rec Reference 15/WA/0414 
on 25 November 2015) and the NHSBT Research and 
Development Committee (NHSBT ID: AP-15–02 on 
24 November 2015).
The design and methods are informed by an ethical 
framework developed by the UK-based researchers for 
undertaking research with family members who are 
approached about organ donation and draws on the expe-
riences of researchers working with the bereaved.28–36 
Independent governance will be provided by a steering 
group.
A key component of the ethical nature of the study 
will be the professional development and training 
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elements to support SNODs and research officers to 
conduct the study in a respectful and sensitive way. 
We will dovetail the bereavement support offered 
by researchers to participants with the bereavement 
services offered by intensive care units in NHS Health 
Boards where potential organ donors are cared for with 
their families, and information provided on bereave-
ment support services shared by SNODs in NHSBT 
teams covering Wales. In addition, in any contact 
with participants we will share a bilingual informa-
tion leaflet on CRUSE Bereavement Care Cymru, in 
case families would prefer to access free support and 
counselling outside of a NHS context. In appreciation 
of their support, research team members will plan a 
fund-raising activity during the study to make a dona-
tion to Cruse Bereavement Care Cymru.
Additional information concerning the specific ethical 
and data protection37 issues, proposed strategies and data 
sharing agreement can be found in (online supplemen-
tary file 5).
patient and public involvement
Prior to commencement of the study, contextual baseline 
engagement with the public has consisted of six discussion 
groups and seven face-to-face interviews involving 52 partic-
ipants. This contextual work was undertaken by the Welsh 
Government.19 Each group was recruited to include a mix 
of people in terms of awareness of the NHS Organ Donor 
Register and included some who had joined the Register 
and/or carried a donor card. Black and Minority Ethnic 
people formed part of the sample and included Pakistani, 
African Caribbean, Nigerian and Chinese participants. Each 
group contained a mix of men and women and the sample 
was broadly stratified by age and socioeconomic grouping. 
Two groups were conducted in the Welsh language. In 
addition, 1006 members of the public responded to a base-
line Welsh Omnibus attitudinal survey.8 Patient and public 
involvement representatives were involved in prioritising 
the question and in deciding to fund the study. The leading 
charities for supporting deceased organ donor families 
and people with kidney failure requiring a transplant 
have helped shape the design and advised on appropriate 
methods of data collection.
The Welsh Government hosted a conference in 
September 2015 involving those affected by deceased 
organ donation and healthcare professionals involved 
in the donation process to explore the implementation 
and implications of the Act from different perspectives 
and to explore how best to evaluate the Act and what 
outcomes from different perspectives are important. 
These perspectives have been incorporated into the 
study design. PPI will continue during the study through 
to dissemination.38 39
building research capacity
A secondary aim of the study is to increase the confidence 
and capacity of NHSBT and PPI representatives to collab-
orate in future studies in this field.
In following Prudent healthcare principles,39 we will use 
a coproduction approach, which means that the research 
team will work as equal partners and in collaboration with 
NHSBT who have a remit to support relevant research 
activity, and with a range of key professional stakeholders 
and PPI representatives to conduct the study. The copro-
duction element is critical to the success of the study 
and will involve a strong research training and capacity 
building component for NHSBT teams and PPI repre-
sentatives working in Wales. We have worked closely 
with policy and clinical leads from Welsh Government 
and NHSBT to ensure that the proposed coproductive 
methods of data collection and participant recruitment 
are feasible, sensitive to the needs of potential donor 
families and NHS staff and fulfil the high ethical and data 
protection requirements for data sharing between two 
organisations.
Three development opportunities will bring NHSBT 
staff and PPI representatives together. At the beginning 
of the study, we will facilitate professional development 
meetings with SNODs and managers to design the data 
collection tools. At the end of the first year of data collec-
tion, we will present initial findings at a professional devel-
opment meeting with collaborating staff from NHSBT, 
clinical co-applicants, policy makers and PPI representa-
tives to see what shared learning could be used to further 
enhance practice development and support study data 
collection. We will facilitate another meeting at the end 
of the study to present key findings.
Expected outcomes
The most important outcome will be a research-in-
formed and clearer, shared understanding of deceased 
donor consent decisions, and in particular the reasons 
why people continue to refuse to support consent in a 
‘soft opt-out’ system, to feed back into further policy 
and practice development. In addition, staff in NHSBT 
covering Wales and PPI representatives will have devel-
oped additional confidence and research capacity and 
capability to undertake further and equally challenging 
studies.
Impact and dissemination
The study has potential for high impact as success of this 
Prudent health policy is dependent on the people of Wales 
engaging with the principles of deemed consent and donor 
registration and honouring the deceased person’s dona-
tion decision. If sufficient people agree and change their 
behaviour to favour the principles of the ‘soft opt-out’, 
then the policy will likely realise the anticipated benefits 
for patients. If sufficient people disagree then nothing will 
change and the anticipated increased number of patients 
who benefit from cost-effective transplants will not be 
realised.
Understanding why people do not register on the 
organ donor register or why family/appointed represen-
tatives still contest the decision to donate made by the 
deceased person will have an impact on the design of 
10 Noyes J, et al. BMJ Open 2017;7:e017287. doi:10.1136/bmjopen-2017-017287
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future interventions to improve organ and tissue dona-
tion rates in Wales.
The main mechanism of dissemination, knowledge 
transfer and maximising impact is through the uptake of 
project outputs by policy makers, clinicians and the public 
through a coproductive continuous quality improvement 
approach in line with Prudent healthcare principles.15 16 
There are key elements known to affect the resources 
required for managing successful coproductive dissem-
ination processes and these elements are built into the 
project design, including:
 ► motivating change: creating readiness for change and 
overcoming resistance;
 ► creating a vision: mission, valued outcomes and condi-
tions, midpoint goals and feedback;
 ► developing political support: assessing change agent 
power, identifying key stakeholders, influencing 
stakeholders;
 ► feeding back findings and jointly determining their 
meaning for various stakeholders;
 ► sustaining momentum: providing resources for 
professional development and research capacity 
building, building support systems for change agents, 
developing new competencies and skills, reinforcing 
new behaviours.40
Other effective elements of knowledge transfer include 
publication of research results in leading journals, 
and presentations at local, national and international 
conferences in the field. The research team has already 
demonstrated a high-quality publication record, and will 
continue to do so, adopting an open-access policy. We will 
also produce bilingual lay summaries.
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